Q2 FY2027 · ended Jul 31, 2026 · Revenue $350.73M, +7.6% YoY · Filed Aug 27, 2026
Healthequity, Inc. (HQY) files with the SEC under industry code 7389, Services-Business Services, NEC. In Q2 of fiscal 2027, the quarter ended Jul 31, 2026, it reported revenue of $350.7 million and net income of $65.6 million. Free cash flow was $135.2 million. As of Jul 31, 2026 it held $256.0 million in cash and investments and $971.0 million in total debt.
Revenue
$350.73M
+7.6% vs year-ago quarter
Net income
$65.64M
+9.7% vs year-ago quarter
Operating cash flow
$136.16M
+0.2% vs year-ago quarter
Free cash flow
$135.18M
+0.1% vs year-ago quarter
EPS
$0.78
+14.7% vs year-ago quarter
Dividend per share
None
Shares outstanding
82.72M
-4.0% vs year-ago quarter
Net cash
$-715.01M
Q2 FY2027
Operating margin
25.8%
TTM
Company profile
- Industry
- Services-Business Services, NEC (SIC 7389)
- Listed as
- HQY (Nasdaq)
- Fiscal year ends
- January 31
- Incorporated in
- DE
- Headquarters
- Draper, UT
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1428336
- Former names
- HEALTHEQUITY INC (until Jun 6, 2019)
Other Services-Business Services, NEC companies
- Visa Inc. V
- Mastercard Inc MA
- Alibaba Group Holding Ltd BABA
- Accenture plc ACN
- Uber Technologies, Inc UBER
- PDD Holdings Inc. PDD
- Mercadolibre Inc MELI
- DoorDash, Inc. DASH
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2027 Jul 31, 2026 |
Q1 FY2027 Apr 30, 2026 |
Q4 FY2026 Jan 31, 2026 |
Q3 FY2026 Oct 31, 2025 |
Q2 FY2026 Jul 31, 2025 |
|---|---|---|---|---|---|
| Revenue | $350.7M | $354.6M | $334.6M | $322.2M | $325.8M |
| Operating income | $98.7M | $103.0M | $71.1M | $78.7M | $89.6M |
| Net income | $65.6M | $69.4M | $49.7M | $51.7M | $59.9M |
| Diluted EPS | $0.78 | $0.82 | $0.57 | $0.59 | $0.68 |
| Operating cash flow | $136.2M | $97.5M | $117.9M | $138.6M | $135.9M |
| Free cash flow | $135.2M | $97.2M | $117.6M | $137.8M | $135.1M |
| Total assets | $3.3B | $3.3B | $3.4B | $3.4B | $3.4B |
| Total liabilities | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B |
| Stockholders' equity | $2.0B | $2.0B | $2.1B | $2.1B | $2.1B |
| Cash and investments | $256.0M | $265.4M | $318.9M | $309.3M | $304.5M |
| Total debt | $971.0M | $984.7M | $1.0B | $1.0B | $1.1B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 9, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 30, 2026 | Sep 24, 2026 |
| 10-Q | Quarterly report | Aug 27, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 27, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2026 | Jun 25, 2026 |
| 10-Q | Quarterly report | May 28, 2026 | Apr 30, 2026 |
All 1003 Healthequity, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.